AAS
CVS icon

Avantax Advisory Services’s CVS Health CVS Stock Holding History

Avantax Advisory Services’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$10.5M Sell
152,792
-7,972
-5% -$523K 0.06% 261
2025
Q1 		$10.9M Buy
160,764
+32,873
+26% +$1.97M 0.07% 225
2024
Q4 		$5.74M Sell
127,891
-33,057
-21% -$1.85M 0.04% 358
2024
Q3 		$10.1M Sell
160,948
-5,344
-3% -$312K 0.07% 214
2024
Q2 		$9.82M Buy
166,292
+92,201
+124% +$5.77M 0.07% 209
2024
Q1 		$5.91M Sell
74,091
-64,202
-46% -$4.9M 0.05% 270
2023
Q4 		$10.9M Sell
138,293
-19,995
-13% -$1.42M 0.11% 145
2023
Q3 		$11.1M Buy
158,288
+3,713
+2% +$263K 0.12% 130
2023
Q2 		$10.7M Buy
154,575
+7,092
+5% +$505K 0.12% 139
2023
Q1 		$11M Buy
147,483
+21,194
+17% +$1.78M 0.13% 131
2022
Q4 		$11.8M Buy
126,289
+5,342
+4% +$515K 0.16% 110
2022
Q3 		$11.5M Buy
120,947
+3,946
+3% +$391K 0.18% 92
2022
Q2 		$10.8M Buy
117,001
+212
+0.2% +$20.7K 0.16% 96
2022
Q1 		$11.8M Buy
116,789
+12,108
+12% +$1.27M 0.16% 97
2021
Q4 		$10.8M Buy
104,681
+6,192
+6% +$572K 0.16% 101
2021
Q3 		$8.34M Buy
98,489
+11,769
+14% +$986K 0.14% 116
2021
Q2 		$7.25M Buy
86,720
+14,705
+20% +$1.2M 0.13% 121
2021
Q1 		$5.43M Buy
72,015
+7,098
+11% +$517K 0.12% 144
2020
Q4 		$4.44M Sell
64,917
-61,739
-49% -$4.02M 0.11% 146
2020
Q3 		$7.42M Buy
126,656
+73,827
+140% +$4.59M 0.12% 141
2020
Q2 		$3.43M Sell
52,829
-14,424
-21% -$908K 0.1% 150
2020
Q1 		$3.99M Buy
67,253
+13,140
+24% +$877K 0.12% 119
2019
Q4 		$4.02M Buy
54,113
+28,488
+111% +$2M 0.09% 134
2019
Q3 		$1.62M Buy
25,625
+13,661
+114% +$810K 0.07% 148
2019
Q2 		$652K Buy
11,964
+112
+0.9% +$6.03K 0.03% 256
2019
Q1 		$639K Sell
11,852
-1,163
-9% -$71.8K 0.03% 243
2018
Q4 		$854K Buy
+13,015
New +$972K 0.14% 148

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Avantax Advisory Services's CVS Position: Q2 2025 in Review

Avantax Advisory Services reduced its CVS Health (CVS) stake by 5% in Q2 2025, selling an estimated $523K and leaving 152,792 shares worth $10.5M. The position accounts for 0.06% of the portfolio, ranked #261.

Avantax Advisory Services first reported a position in CVS in Q4 2018 and has held it in 27 quarters since. The position peaked at $11.8M in Q1 2022. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Avantax Advisory Services held 152,792 shares of CVS Health worth $10.5M as of Q2 2025.
  • Avantax Advisory Services sold 7,972 CVS Health shares in Q2 2025, an estimated $523K.
  • CVS Health made up 0.06% of Avantax Advisory Services's portfolio in Q2 2025, its #261 holding.
  • Avantax Advisory Services first reported a position in CVS Health in Q4 2018 and has held it in 27 quarters since.
  • Avantax Advisory Services's CVS Health position peaked at $11.8M in Q1 2022.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.